Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...

Novartis is stopping the development of ianalumab in hidradenitis suppurativa (HS) after a Phase IIb proof-of-concept trial ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Marseille, France Monday, July 21, 2025, 12:00 Hrs [IST] ...

A new annotation approach based on cross-species conservation reveals regulatory roles of transposons in human development.

Stellantis said it would end efforts to develop hydrogen vehicles as it focuses its resources on electric cars and hybrids to ...

Kennedy Jr. has downplayed the effectiveness of the long-used vaccine and instead promoted the development of new treatments ...

Imugene announces phase 1b trial evaluating azer-cel in patients with relapsed/refractory diffuse large B-cell lymphoma: Sydney Wednesday, July 16, 2025, 15:30 Hrs [IST] Imugene L ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

Vitamin B12 is among the most important nutrients your body needs for growth, development, and smooth functioning. your body, ...

Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, yet many tumors remain resistant. Now, ...

Union Minister Pralhad Joshi highlights India's commitment to renewable energy leadership under Aatmanirbhar Bharat. Through ...